Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 1/2015

01.01.2015 | Original Article – Cancer Research

Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study

verfasst von: Peter Dieringer, Evan M. Klass, Brenna Caine, Julie Smith-Gagen

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The incidence of large thyroid tumors has increased over the past decades, suggesting that improved diagnosis is not the only driver of increased thyroid cancer incidence. Obesity has recently been implicated as an independent risk factor for thyroid cancer in specific populations. We aimed to investigate whether thyroid tumor size and advanced stage of diagnosis is associated with the obesity epidemic, for the first time, in a US population-based cohort.

Methods

We leveraged existing data and linked 1,077 papillary thyroid cancer patients from the Nevada Central Cancer Registry to the Department of Motor Vehicle dataset. Tumor size and cancer stage were assessed from cancer registry records, and obesity was obtained using height and weight in the Department of Motor Vehicle records and measured by a body mass index greater than 25 kg/m2.

Results

Crude analysis showed obesity as was associated with tumors larger than 2 cm [odds ratio (OR) 1.50, p = 0.0423] and advanced cancer stage (stage III and IV) (OR 1.40, p = 0.0111). After adjusting for confounders, a significant association was still observed between obesity and tumor larger than 2 cm (OR 1.53, p = 0.0339). A marginally significant association was shown between obesity and advanced cancer stage (OR 1.29, p = 0.0649).

Conclusion

As thyroid cancer incidence continues to increase, this study’s finding that obesity was significantly associated with larger tumor size and marginally significantly associated with advanced tumor stage can help establish new preventative actions and identify new target populations for interventions.
Literatur
Zurück zum Zitat Brindel P, Doyon F, Rachédi F, Boissin JL, Sebbag J, Shan L et al (2009) Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control 20(5):581–590PubMedCrossRef Brindel P, Doyon F, Rachédi F, Boissin JL, Sebbag J, Shan L et al (2009) Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control 20(5):581–590PubMedCrossRef
Zurück zum Zitat Cléro E, Leux C, Brindel P, Truong T, Anger A, Teinturier C et al (2010) Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid 20(11):1285–1293PubMedCrossRef Cléro E, Leux C, Brindel P, Truong T, Anger A, Teinturier C et al (2010) Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid 20(11):1285–1293PubMedCrossRef
Zurück zum Zitat Collaborative Staging Task Force of the American Joint Committee on Cancer (2004) Collaborative Staging Manual and Coding Instructions, version 1.0: Jointly published by American Joint Committee on Cancer (Chicago, IL) and U.S. Department of Health and Human Services (Bethesda, MD) Collaborative Staging Task Force of the American Joint Committee on Cancer (2004) Collaborative Staging Manual and Coding Instructions, version 1.0: Jointly published by American Joint Committee on Cancer (Chicago, IL) and U.S. Department of Health and Human Services (Bethesda, MD)
Zurück zum Zitat Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M et al (2002) Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer 38(13):1762–1768PubMedCrossRef Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M et al (2002) Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer 38(13):1762–1768PubMedCrossRef
Zurück zum Zitat Cramer JD, Fu PF, Harth KC, Margevicius S, Wilhelm SM (2010) Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results National Cancer Data Registry. Surgery 148(6):1147–1152PubMedCrossRef Cramer JD, Fu PF, Harth KC, Margevicius S, Wilhelm SM (2010) Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results National Cancer Data Registry. Surgery 148(6):1147–1152PubMedCrossRef
Zurück zum Zitat Cui YD, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL (2002) Body mass and stage of breast cancer at diagnosis. Int J Cancer 98(2):279–283PubMedCrossRef Cui YD, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL (2002) Body mass and stage of breast cancer at diagnosis. Int J Cancer 98(2):279–283PubMedCrossRef
Zurück zum Zitat Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. J Am Med Assoc 295(18):2164–2167CrossRef Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. J Am Med Assoc 295(18):2164–2167CrossRef
Zurück zum Zitat De Nunzio C, Albisinni S, Freedland SJ, Miano L, Cindolo L, Agro EF et al (2013) Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study. Urol Oncol 31(7):997–1002PubMedCrossRef De Nunzio C, Albisinni S, Freedland SJ, Miano L, Cindolo L, Agro EF et al (2013) Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study. Urol Oncol 31(7):997–1002PubMedCrossRef
Zurück zum Zitat Deglise C, Bouchardy C, Burri M, Usel M, Neyroud-Caspar I, Vlastos G et al (2010) Impact of obesity on diagnosis and treatment of breast cancer. Breast Cancer Res Treat 120(1):185–193PubMedCrossRef Deglise C, Bouchardy C, Burri M, Usel M, Neyroud-Caspar I, Vlastos G et al (2010) Impact of obesity on diagnosis and treatment of breast cancer. Breast Cancer Res Treat 120(1):185–193PubMedCrossRef
Zurück zum Zitat Enewold L, Zhu KM, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18(3):784–791PubMedCentralPubMedCrossRef Enewold L, Zhu KM, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18(3):784–791PubMedCentralPubMedCrossRef
Zurück zum Zitat Fahey TJ, Reeve TS, Delbridge L (1995) Increasing incidence and changing presentation of thyroid-cancer over a 30-year period. Br J Surg 82(4):518–520PubMedCrossRef Fahey TJ, Reeve TS, Delbridge L (1995) Increasing incidence and changing presentation of thyroid-cancer over a 30-year period. Br J Surg 82(4):518–520PubMedCrossRef
Zurück zum Zitat Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998) Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes 22(1):39–47CrossRef Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998) Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes 22(1):39–47CrossRef
Zurück zum Zitat Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US Adults, 1999–2010. J Am Med Assoc 307(5):491–497CrossRef Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US Adults, 1999–2010. J Am Med Assoc 307(5):491–497CrossRef
Zurück zum Zitat Gorber SC, Tremblay M, Moher D, Gorber B (2007) Diagnostic in obesity comorbidities—a comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev 8(4):307–326PubMedCrossRef Gorber SC, Tremblay M, Moher D, Gorber B (2007) Diagnostic in obesity comorbidities—a comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev 8(4):307–326PubMedCrossRef
Zurück zum Zitat Haakinson DJ, Leeds SG, Dueck AC, Gray RJ, Wasif N, Stucky CCH et al (2012) The impact of obesity on breast cancer: a retrospective review. Ann Surg Oncol 19(9):3012–3018PubMedCrossRef Haakinson DJ, Leeds SG, Dueck AC, Gray RJ, Wasif N, Stucky CCH et al (2012) The impact of obesity on breast cancer: a retrospective review. Ann Surg Oncol 19(9):3012–3018PubMedCrossRef
Zurück zum Zitat Han JM, Kim TY, Jeon MJ, Yim JH, Kim WG, Song DE et al (2013) Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol 168(6):879–886PubMedCrossRef Han JM, Kim TY, Jeon MJ, Yim JH, Kim WG, Song DE et al (2013) Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol 168(6):879–886PubMedCrossRef
Zurück zum Zitat Kahn C, Simonella L, Sywak M, Boyages S, Ung O, O’Connell D (2012) Postsurgical pathology reporting of thyroid cancer in New South Wales, Australia. Thyroid 22(6):604–610PubMedCrossRef Kahn C, Simonella L, Sywak M, Boyages S, Ung O, O’Connell D (2012) Postsurgical pathology reporting of thyroid cancer in New South Wales, Australia. Thyroid 22(6):604–610PubMedCrossRef
Zurück zum Zitat Kilfoy BA, Zheng TZ, Holford TR, Han XS, Ward MH, Sjodin A et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5):525–531PubMedCentralPubMedCrossRef Kilfoy BA, Zheng TZ, Holford TR, Han XS, Ward MH, Sjodin A et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5):525–531PubMedCentralPubMedCrossRef
Zurück zum Zitat Kim JY, Jung EJ, Jeong SH, Jeong CY, Ju YT, Lee YJ et al (2011) The indices of body size and aggressiveness of papillary thyroid carcinoma. J Korean Surg Soc 80(4):241–244PubMedCentralPubMedCrossRef Kim JY, Jung EJ, Jeong SH, Jeong CY, Ju YT, Lee YJ et al (2011) The indices of body size and aggressiveness of papillary thyroid carcinoma. J Korean Surg Soc 80(4):241–244PubMedCentralPubMedCrossRef
Zurück zum Zitat Kim HJ, Kim NK, Choi JH, Sohn SY, Kim SW, Jin SM et al (2013) Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol (Oxf) 78(1):134–140CrossRef Kim HJ, Kim NK, Choi JH, Sohn SY, Kim SW, Jin SM et al (2013) Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol (Oxf) 78(1):134–140CrossRef
Zurück zum Zitat Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y et al (2011) Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev 20(3):464–472PubMedCentralPubMedCrossRef Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y et al (2011) Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev 20(3):464–472PubMedCentralPubMedCrossRef
Zurück zum Zitat Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the french thyroid cancer committee. Thyroid 14(12):1056–1060PubMedCrossRef Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the french thyroid cancer committee. Thyroid 14(12):1056–1060PubMedCrossRef
Zurück zum Zitat Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B (2008) Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111(2):329–342PubMedCrossRef Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B (2008) Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111(2):329–342PubMedCrossRef
Zurück zum Zitat Marcello MA, Sampaio AC, Geloneze B, Vasques AC, Assumpcao LV, Ward LS (2012) Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer. Nutr Cancer 64(8):1190–1195PubMedCrossRef Marcello MA, Sampaio AC, Geloneze B, Vasques AC, Assumpcao LV, Ward LS (2012) Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer. Nutr Cancer 64(8):1190–1195PubMedCrossRef
Zurück zum Zitat Marcello MA, Cunha LL, Batista FA, Ward LS (2014) Obesity and thyroid cancer. Endocr Relat Cancer [Epub ahead of print] Marcello MA, Cunha LL, Batista FA, Ward LS (2014) Obesity and thyroid cancer. Endocr Relat Cancer [Epub ahead of print]
Zurück zum Zitat Mijovic T, How J, Payne RJ (2011) Obesity and thyroid cancer. Front Biosci (Schol Ed) 3:555–564CrossRef Mijovic T, How J, Payne RJ (2011) Obesity and thyroid cancer. Front Biosci (Schol Ed) 3:555–564CrossRef
Zurück zum Zitat Paes JE, Hua K, Nagy R, Kloos RT, Jarjoura D, Ringel MD (2010) The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab 95(9):4244–4250PubMedCentralPubMedCrossRef Paes JE, Hua K, Nagy R, Kloos RT, Jarjoura D, Ringel MD (2010) The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab 95(9):4244–4250PubMedCentralPubMedCrossRef
Zurück zum Zitat Rinaldi S, Lise M, Clavel-Chapelon F, Boutron-Ruault MC, Guillas G, Overvad K et al (2012) Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer 131(6):E1004–E1014PubMedCrossRef Rinaldi S, Lise M, Clavel-Chapelon F, Boutron-Ruault MC, Guillas G, Overvad K et al (2012) Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer 131(6):E1004–E1014PubMedCrossRef
Zurück zum Zitat Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM et al (1995) Thyroid-cancer after exposure to external radiation—a pooled analysis of 7 studies. Radiat Res 141(3):259–277PubMedCrossRef Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM et al (1995) Thyroid-cancer after exposure to external radiation—a pooled analysis of 7 studies. Radiat Res 141(3):259–277PubMedCrossRef
Zurück zum Zitat Stommel M, Schoenborn CA (2009) Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001–2006. BMC Public Health 9:421PubMedCentralPubMedCrossRef Stommel M, Schoenborn CA (2009) Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001–2006. BMC Public Health 9:421PubMedCentralPubMedCrossRef
Zurück zum Zitat Vucenik I, Stains JP (2012) Obesity and cancer risk: evidence, mechanisms, and recommendations. Nutr Phys Activ Aging Obes Cancer 1271:37–43 Vucenik I, Stains JP (2012) Obesity and cancer risk: evidence, mechanisms, and recommendations. Nutr Phys Activ Aging Obes Cancer 1271:37–43
Zurück zum Zitat Zhao ZG, Guo XG, Ba CX, Wang W, Yang YY, Wang J et al (2012) Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 40(6):2041–2050PubMedCrossRef Zhao ZG, Guo XG, Ba CX, Wang W, Yang YY, Wang J et al (2012) Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 40(6):2041–2050PubMedCrossRef
Metadaten
Titel
Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study
verfasst von
Peter Dieringer
Evan M. Klass
Brenna Caine
Julie Smith-Gagen
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 1/2015
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1792-2

Weitere Artikel der Ausgabe 1/2015

Journal of Cancer Research and Clinical Oncology 1/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.